Literature DB >> 29112277

SDS-PAGE procedure: Application for characterization of new entirely uncharged nucleic acids analogs.

Anna S Pavlova1, Evgeniya S Dyudeeva2, Maxim S Kupryushkin1, Nariman V Amirkhanov1, Dmitrii V Pyshnyi1,2, Inna A Pyshnaya1.   

Abstract

SDS-PAGE is considered to be a universal method for size-based separation and analysis of proteins. In this study, we applied the principle of SDS-PAGE to the analysis of new entirely uncharged nucleic acid (NA) analogues, - phosphoryl guanidine oligonucleotides (PGOs). The procedure was also shown to be suitable for morpholino oligonucleotides (PMOs) and peptide nucleic acids (PNAs). It was demonstrated that SDS can establish hydrophobic interactions with these types of synthetic NAs, giving them a net negative charge and thus making these molecules mobile in polyacrylamide slab gels under the influence of an electric field.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PMO; Phosphoryl guanidine; SDS-PAGE; Uncharged nucleic acid analogs

Mesh:

Substances:

Year:  2017        PMID: 29112277     DOI: 10.1002/elps.201700415

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  2 in total

1.  Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells.

Authors:  Maxim S Kupryushkin; Anton V Filatov; Nadezhda L Mironova; Olga A Patutina; Ivan V Chernikov; Elena L Chernolovskaya; Marina A Zenkova; Dmitrii V Pyshnyi; Dmitry A Stetsenko; Sidney Altman; Valentin V Vlassov
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

2.  Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer.

Authors:  Mirina Sakhi; Abad Khan; Zafar Iqbal; Ismail Khan; Abida Raza; Asmat Ullah; Fazli Nasir; Saeed Ahmad Khan
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.